col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


79 Results       Page 1

 [1] 
Elsevier: Lung Cancer
  original article Date Title Authors   Max. 6 Authors
1 [GO] 2024―Sep―02 What’s behind thoracic surgery explosion in young patients under the age of 40 in Wuhan after COVID-19 outbreak? Chang Zhu
2 [GO] 2024―Apr―17 152 A retrospective audit comparing toxicity and survival outcomes in patients who received palliative radiotherapy for NSCLC using the COVID-19 hypofractionated regime with patients treated pre-pandemic using standard RCR recommended regimes Lynn Bell, Louise Turtle, Tony Pope, David Cobben, Anoop Haridass
3 [GO] 2024―Apr―17 101 Real-world analysis of the impact of pemetrexed in first-line maintenance (1LM) with immunotherapy (IO) for non-squamous (NSQ) advanced/metastatic non-small cell lung cancer (a/mNSCLC) lacking targetable mutations, prior to and during the COVID-19 pandemic Fabio Gomes, Niall Gilding, Vivian Tan, Katerina Christoforou, Joanne Rule, Amine Aziez, Adam Januszewski, Anna Minchom
4 [GO] 2024―Apr―17 121 Ongoing impact of the pandemic on cancer services Rodanthe Nixon, Holly Emms, Carlos Pereira Chilima, Samreen Afroz, Sophie Goodrum
5 [GO] 2023―Nov―13 Disparities in outcomes between Black and White patients in North America with thoracic malignancies and COVID-19 infection (TERAVOLT) Laura Burns, Chih-Yuan Hsu, Jennifer G. Whisenant, Melina E. Marmarelis, Carolyn J. Presley, Karen L. Reckamp, Hina Khan, Mary Jo Fidler, Christine M. Bestvina, Julie Brahmer, Sonam Puri, Jyoti D. Patel, Balazs Halmos, Fred R. Hirsch, Stephen V. Liu, Daniel B. Costa, Sarah B. Goldberg, Lawrence E. Feldman, Hirva Mamdani, Matthew Puc, Aaron S. Mansfield, Nahida Islam, Katherine A. Scilla, Marina C. Garassino, Leora Horn, Solange Peters, Heather A. Wakelee, Marjory Charlot, Umit Tapan
6 [GO] 2023―Aug―09 Immunogenicity of COVID-19 vaccines in lung cancer patients Mariano Provencio, Anna Estival, Fernando Franco, Guillermo López-Vivanco, María Saigí, Hugo Arasanz, Pilar Diz, Enric Carcereny, Javier García, Carlos Aguado, Joaquín Mosquera, Eluska Iruarrizaga, Margarita Majem, Joaquim Bosch-Barrerra, Xavier Mielgo-Rubio, María Guirado, Óscar Juan-Vidal, Ana Blasco, Clara Lucía Gozálvez, Anabel Del Barrio, Teresa De Portugal, Ana López-Martín, Gloria Serrano, Begoña Campos, Judit Rubio, Silvia Catot, Beatriz Esteban, Juan Luis Martí-Ciriquian, Edel del Barco, Virginia Calvo
7 [GO] 2023―Apr―24 Real world experience of hypofractionated radical radiotherapy for non-small cell lung cancer (NSCLC) during the COVID-19 pandemic: a well-tolerated radiotherapy schedule with acceptable progression-free (PFS) and overall survival (OS) Nidhish Jeyin, Ghirmay Kidane, Dominic Withers, Simon Ball, Kathryn Tarver
8 [GO] 2023―Apr―24 Looking back at role of therapeutic bronchoscopy during the COVID-19 pandemic Matthew Wright, Amyn Bhamani, Rosalind Shea, Rimsha Khan, Ricky Thakrar, Sam Janes, Neal Navani
9 [GO] 2023―Apr―24 An integrated Allied Healthcare Professional rehabilitation service for patients with thoracic cancer: an evaluation of patient’s rehabilitations needs post COVID-19, and service improvement project Faye Dickinson, Jennie Blake, Katherine Whiteaway, Rachel Bracegirdle, Ashton Brower
10 [GO] 2023―Apr―24 Changes in diagnostic practice and stage at resection in non-small cell lung cancer during the COVID-19 pandemic: a four-year retrospective survey Chris Bell, John Gosney
11 [GO] 2023―Apr―24 The Peninsula stage III non-small cell lung cancer audit: assessing the impact of COVID-19 on treatment decisions Philippa Smith, Hannah Bond, Eleanor Weir, Benjamin Crook, Victoria Ford, Ian Fraser, Lyndsey Phelps, Adam Muse
12 [GO] 2023―Apr―24 Moral distress in mesothelioma and lung cancer nurses during the COVID-19 pandemic: insights from a UK survey Sarah Hargreaves, Karen Clayton, Lorraine Creech, Liz Darlison, Stephanie Ejegi-Memeh, Jackie Fenemore, Clare Gardiner, Bethany Taylor, Angela Tod
13 [GO] 2023―Apr―24 Increased proportion of patients diagnosed with lung cancer as a result of an acute hospital admission during the COVID-19 pandemic, and associated inequalities Rebecca Taylor
14 [GO] 2023―Apr―24 Impact of COVID-19 lockdown on new lung cancer diagnosis at the Royal Gwent Hospital Aarij Elahi, Tanbir Kalam, Sam Williams, Alina Ionescu
15 [GO] 2023―Mar―23 How much have covid-19 pandemic waves impacted the number of lung cancer surgeries Amanda Ramos da Cunha, José Leopoldo Ferreira Antunes
16 [GO] 2022―Aug―17 The impact of COVID-19 on thoracic surgical procedures in Japan: analysis of data from the National Clinical Database Yukio Sato, Hiroyuki Yamamoto, Norihiko Ikeda, Hiroshi Konishi, Shunsuke Endo, Yoshinori Okada, Haruhiko Kondo, Yasushi Shintani, Shinichi Toyooka, Hiroshige Nakamura, Yasushi Hoshikawa, Toyofumi Fengshi Chen-Yoshikawa, Ichiro Yoshino, Tadao Kakizoe, Masayuki Chida
17 [GO] 2022―Feb―10 Incidence and outcomes of central airway obstruction in new lung cancer diagnoses prior to and during COVID-19 Irfan Zaki, Parniya Arooj, Daniel Crowle, Alice Talbot, John Corcoran, Adrian Marchbank, Thomas Nicholson, Cyrus Daneshvar
18 [GO] 2022―Feb―10 The impact of COVID-19 on national targets in radical lung cancer radiotherapy: a single centre clinical audit Kimberley Durno, John Conibear
19 [GO] 2022―Feb―10 The impact of virtual lung MDT meetings (MDTMs) in response to the COVID-19 pandemic Hanna Groothuizen, Eunice Aroyewun, Magdalena Zasada, Jenny Harris, Madeleine Hewish, Cath Taylor
20 [GO] 2022―Feb―10 Impact of the COVID-19 pandemic first wave on the volume and type of systemic anticancer therapy (SACT) delivered for thoracic malignancies Marios Decatris, Nowrina Khan, Philip Ryan, Aled Phillips, Sherouk El-Batrawy, Maninder Kalkat, Caitlin Bowden, Mark Hayes, Philippe Taniere, Joy Thomas, Ingrid Du Rand
21 [GO] 2022―Feb―10 The effects of COVID-19 pandemic on lung cancer diagnosis Mariya Sinthiya, John Howells, Gemma Wright, Syed Mehdi
22 [GO] 2022―Feb―10 The impact of the Covid-19 pandemic on lung cancer incidence in England: an analysis of the 2019 and 2020 Rapid Cancer Registration Datasets Savannah Gysling, Helen Morgan, Onosi Ifesemen, Emma O’Dowd, David Baldwin, Doug West, John Conibear, Neal Navani, David Humes, Richard Hubbard
23 [GO] 2022―Feb―10 The continued impact of the COVID-19 pandemic on patient advocacy and support organisations in the UK and Ireland: results from the second Global Lung Cancer Coalition (GLCC) survey Aoife McNamara, Jackie Fenemore, Jesme Fox, Matthew Peters, Sarah Winstone, Riddhi Thakrar
24 [GO] 2022―Feb―10 Impact of the COVID-19 pandemic on suspected lung cancer referrals and subsequent lung cancer diagnoses at North Bristol NHS Trust (NBT) Catherine Coombs, Adriana Pereira, Benjamin Masteman, Abiramy Jeyabalan, Martin Plummeridge, Anna Bibby
25 [GO] 2022―Feb―10 COVID-19 vaccination associated lung mass mimicking a primary lung cancer: a novel manifestation Alexandra Ostler, Georgina Keogh, William Sherwood, Thomas Newsom-Davis
26 [GO] 2022―Feb―10 Contact with lung cancer patients during COVID-19: findings from Ireland and the UK from a global survey of patient experience Aoife McNamara, Jackie Fenemore, Jesme Fox, Mike McKevitt, Riddhi Thakrar
27 [GO] 2022―Feb―10 How has the coronavirus pandemic impacted chemoradiotherapy for stage 3 non-small cell lung cancer (NSCLC) in our centre? Sangary Kathirgamakarthigeyan, Karen Foweraker, Kerstie Johnson, M. Ananth Sivanandan, Abigail Pascoe
28 [GO] 2022―Feb―10 Use of systemic anti-cancer treatments in advanced stage non-small cell lung cancer during the SARS-CoV-2 pandemic in England and Wales: an analysis of the Rapid Cancer Registration Dataset Helen Morgan, Savannah Gysling, Richard Hubbard, John Conibear, Neal Navani, David Baldwin, Emma O’Dowd
29 [GO] 2022―Feb―10 Assessment of the impact of SARS-CoV-2 PCR results amongst thoracic oncology patients Helene Greenwood, Kamalram Thippu Jayaprakash
30 [GO] 2022―Feb―10 A retrospective comparison of diagnostic pathways for lung cancer before and during the pandemic: a single UK centre experience Hannah Lawrence, Paul Beckett
31 [GO] 2021―Jul―19 An invisible group of COVID-19 victims; Impact on Dutch lung cancer care Jesper van Breeschoten, Rawa Ismail, Hans Smit, Olga Schuurbiers, Franz Schramel
32 [GO] 2021―Jul―16 Care Disruptions among Patients with Lung Cancer: A COVID-19 and Cancer Outcomes Study Sheena Bhalla, Ziad Bakouny, Andrew L. Schmidt, Chris Labaki, John A. Steinharter, Douglas A. Tremblay, Mark M. Awad, Alaina J. Kessler, Robert I. Haddad, Michelle Evans, Fiona Busser, Michael Wotman, Catherine R. Curran, Brittney S. Zimmerman, Gabrielle Bouchard, Tomi Jun, Pier V. Nuzzo, Qian Qin, Laure Hirsch, Jonathan Feld, Kaitlin M. Kelleher, Danielle Seidman, Hsin-Hui Huang, Heather M. Anderson-Keightly, Talal El Zarif, Sarah Abou Alaiwi, Talia D. Rosenbloom, Penina S. Stewart, Matthew D. Galsky, Toni K. Choueiri, Deborah B. Doroshow
33 [GO] 2021―May―28 Patient and physician opinion of virtual care in the oncology department of an Irish tertiary care centre in the era of Covid-19 Mary O’Reilly, Mark Doherty
34 [GO] 2021―May―28 Pneumomediastinum, lung cancer and Covid-19 Avinash Aujayeb
35 [GO] 2021―May―28 Stereotactic ablative body radiotherapy (SABR) lung fractionations locally in the COVID-19 era and the impact on dosimetry, resources, early toxicities, and the environment Lyndsey Phelps, Owen Morris, Nicole Dorey, Victoria Ford, Elizabeth Toy, Robert Biggar, Ian Fraser
36 [GO] 2021―May―28 Covid-19 in lung cancer patients in a DGH Avinash Aujayeb
37 [GO] 2021―May―28 The impact of COVID-19 on lung cancer diagnostics - a multicentre comparison of 2019/2020 data Neal Navani, Emma O’Dowd, Laura Succony, Berkay Karahacioglu, Robert Rintoul, Ian Woolhouse, Matthew Evison, Elizabeth Fuller, Amyn Bhamani, Sam Janes, Sinan Eccles, David Baldwin
38 [GO] 2021―May―28 Quantifying the impact of Covid-19 on lung cancer: an urgent need for restoration Emma O’Dowd, Laura Succony, Berkay Karahacioglu, Robert Rintoul, Ian Woolhouse, Matthew Evison, Elizabeth Fuller, Amyn Bhamani, Neal Navani, Sam Janes, Sinan Eccles, David Baldwin
39 [GO] 2021―May―28 Impact of COVID-19 on mesothelioma clinical nurse specialists Bethany Taylor, Angela Tod, Clare Gardiner, Faye Forde, Lorraine Creech, Liz Darlison
40 [GO] 2021―May―28 The effect of COVID-19 on the presentation, staging, and treatment of lung cancer: a retrospective comparative audit of the ‘first wave’ Lisa Evetts, Laura Applegate, Amal Singh, Claire Johnson, Sian Wing, Bernadette McBride, Susan Dargan, Sarah Dawson, Shashank Sharma, Sujoy Saikia, Madeleine Hewish
41 [GO] 2021―May―28 ‘Your cough could be masking something else’ - raising awareness of lung cancer during the Covid-19 pandemic Aoife Mc Namara
42 [GO] 2021―May―28 Adapting lung cancer diagnostics during the Covid-19 pandemic Alex Bull
43 [GO] 2021―May―28 Lung cancer upstaging due to the COVID-19 pandemic Claire Vella, Asif Ashraf, Rajini Sudhir, Daniel Barnes, Jan Brozik, Praveen Rao, Amrita Bajaj, Prajakta Pinglay, Aparna Deshpande, Indrajeet Das, Ruth Machin, Apostolos Nakas, Mohammed Fiyaz Chowdhry, Sridhar Thiagarajan, Samreen Ahmed, Sanjay Agrawal, Jonathan Bennett, Muhammad Tufail
44 [GO] 2021―May―28 Lung cancer diagnosis: impact of the COVID-19 pandemic Sohail Ali, Rahul Dalal, Sharon Longden, Samuel Roberts, Michael Crawford
45 [GO] 2021―May―28 Anxiety and depression in lung cancer patients during Covid-19 pandemic Anitha Jacob, Rahul Mogal, Andrew Barlow, Rama Vancheeswaran
46 [GO] 2021―May―28 Evaluation of telephone consultations for follow up lung cancer patients at Royal Papworth Hospital, undertaken instead of face-to-face consultations during the Covid-19 pandemic Claire Haslop, Michael Bates, Lavinia Magee, Panagiota Chrysikaki
47 [GO] 2021―May―28 A real-world experience of second-line nivolumab in mesothelioma patients during the COVID-19 pandemic Matt Church, Paul Taylor, Yvonne Summers, Raffaele Califano, Shereen Rafee, Mairead Dixon, Lisa Clarke, Laura Cove-Smith
48 [GO] 2021―May―28 Maintaining flexible bronchoscopy and endobronchial ultrasound (EBUS) services during the COVID-19 pandemic at a tertiary centre: the Manchester Royal Infirmary experience Eman Nasr, Durgesh Rana, Nadira Narine, Haider AL-Najjar
49 [GO] 2021―May―28 Use of single-agent pembrolizumab as first-line treatment for non-small cell lung cancer with PDL1 status 50% as per NHS England interim guidance during the COVID-19 pandemic at Southend University Hospital Rebecca Sen, Rafiqul Islam Islam, Harriet Baker, Samuel Kim
50 [GO] 2021―May―28 Analysis of the source of lung cancer diagnoses during 2020 COVID-19 pandemic compared with 2015-2019 in the York and Scarborough NHS Trust Hazel Watchorn
51 [GO] 2021―May―28 Impact of the Covid-19 pandemic on a District General Hospital EBUS service Matthew Wright, Raquel d’Espiney, Jack Mulholland, Malcolm Lawson
52 [GO] 2021―May―28 The impact of the COVID-19 pandemic on lung cancer diagnosis and stage at Plymouth NHS Trust Helen McDill, Maged Hassan, Lindsey Taylor, John Corcoran, Cyrus Daneshvar
53 [GO] 2021―May―28 The impact of the COVID-19 pandemic on patient advocacy and support organisations in the UK and Ireland - results from a Global Lung Cancer Coalition (GLCC) survey Lorraine Dallas, Aoife McNamara, Matthew Peters, Riddhi Thakrar
54 [GO] 2021―May―28 The impact of the COVID-19 pandemic on pleural activity at Plymouth NHS Trust Helen McDill, Maged Hassan, Hem Rai, Avik Ghoshal, Emma Graham, Lindsey Taylor, John Corcoran, Cyrus Daneshvar
55 [GO] 2021―May―28 The impact of the COVID-19 pandemic on referrals and diagnoses of lung cancer in a tertiary hospital Jamie Arberry, Louis Dwyer Hemmings, Jessica Gates, Jennifer Ross, Adrian Draper, Yee-Ean Ong
56 [GO] 2021―May―28 The effects of the COVID-19 pandemic on the lung cancer service at Northwick Park Hospital (NWPH) Lavanya Anandan, Priya Ramachandran, Arnab Datta, Tarangini Sathyamoorthy
57 [GO] 2021―May―28 Impact of the COVID-19 pandemic on the use of systemic anti-cancer therapy for patients diagnosed with malignancy at thoracoscopy in Aneurin Bevan University Health Board Eleanor Barton, Alina Ionescu
58 [GO] 2021―May―28 Delivering bronchoscopy and respiratory diagnostic service for lung cancer during COVID-19 pandemic: a single-centre experience Sue-Lis Yeo, Syed Muneer-ahmed, Mohammed Haris, Muhammad Ganaie, Nadeem Maddekar, Ahmad AbimusaAsa’ari, Imran Hussain, Shahul Leyakathali khan, Shiva Bikmalla
59 [GO] 2021―May―28 No evidence of increased susceptibility to COVID-19 virus among radical lung radiotherapy patients Oskar Lepiarczyk, Jonathan McAleese
60 [GO] 2021―May―28 Lung nodule management in Covid-19: does postponed surveillance matter? Ratnaprashanthika Ratnakumar, Jocelyn Fraser, Rebecca Nicholls, Jennifer Quint, Susannah Bloch
61 [GO] 2021―May―28 Emergency presentation of lung cancer: did it increase during the COVID-19? Cai Lupei, Muhammad Tariq, Imran Hussain, Nadeem Maddekar, Shahul Leyakathali khan
62 [GO] 2021―May―28 Impact of the coronavirus pandemic and national lockdown on a lung cancer service - opportunities for innovation Puneet Malhotra, Amy McIntosh, Pauline Murphy, Victoria Peers
63 [GO] 2021―May―28 The impact of SARS-COV-2 pandemic on pleural services, diagnosis of malignant effusions and junior doctors’ procedural training Nathan Riddell, Artemio Gonzales, Alina Ionescu
64 [GO] 2021―May―28 Does the use of primary care spirometry results in patients referred with suspected lung cancer have potential to avoid delays in the lung cancer referral pathway as a result of the SARS-COV-2 pandemic? Romy Ni Chleirigh, Joshua Macarthur, Sarah MacRae
65 [GO] 2021―May―28 Changes in management for patients with lung cancer referred for radical radiotherapy during the first wave of the COVID 19 pandemic in the UK (COVID-RT Lung) Kathryn Banfill Banfill, Gareth Price, Kate Wicks, Shahreen Ahmad, Hannah Bainbridge, Mike Bayne, Anna Britten, Carrie Carson, Nicole Dorey, Bojidar Goranov, Samir Guglani, Keith Harland, Matthew Hatton, Kamalram Thippu Jayaprakash, Crispin Hiley, Apurna Jegannathen, Pek Koh, Hannah Lord, Dila Mokhtar, Niki Panakis, Clive Peedell, Tony Pope, Adam Peters, Ceri Powell, Claire Stilwell, Sarah Treece, Betsan Thomas, Elizabeth Toy, Suyun Zhou, Corinne Faivre-Finn
66 [GO] 2021―May―28 Lung cancer treatment during a pandemic: how have multi-disciplinary teams changed? James Hargrave, Claire Hastings, Jackie Fenemore, Lorraine Dallas, Tom Newsom-Davis, Robert Rintoul
67 [GO] 2021―May―14 Lung Cancer Patients with COVID-19 in Spain: GRAVID study Mariano Provencio, José María Mazarico Gallego, Antonio Calles, Mónica Antoñanzas, Cristina Pangua, Xabier Mielgo Rubio, Ernest Nadal, Rafael López Castro, Ana López-Martín, Edel del Barco, Manuel Dómine, Fernando Franco, Pilar Diz, Carmen Sandoval, Elia Sais Girona, Ivana Sullivan, Mª Ángeles Sala, Gema García Ledo, Marc Cucurull, Joaquín Mosquera, Mireia Martínez, Luis Enrique Chara, Edurne Arriola, Beatriz Esteban Herrera, José Ramón Jarabo, Rosa Álvarez Álvarez, Javier Baena, María González Cao
68 [GO] 2021―May―08 Impact of COVID-19 on the management of patients with thoracic cancers in a tertiary referral center Clémence Basse, Catherine Daniel, Alain Livartowski, Sophie Beaucaire-Danel, Nicolas Girard
69 [GO] 2021―May―05 Higher mortality in lung cancer patients with COVID-19? A systematic review and meta-analysis Haike Lei, Yue Yang, Wei Zhou, Mengyang Zhang, Yang Shen, Dan Tao, Lulu Wang, Qianqian Lei, Ying Wang, Yongzhong Wu
70 [GO] 2021―Apr―30 Safety monitoring of 2 and 4-weekly adjuvant durvalumab for patients with Stage III NSCLC; implications for the COVID-19 pandemic and beyond Kroopa Joshi, Abdul Muhith, Mariam Obeid, Charlotte Milner-Watts, Nadia Yousaf, Sanjay Popat, Michael Davidson, Jaishree Bhosle, Mary O’Brien, Anna Minchom
71 [GO] 2020―Dec―24 Evaluation of variant frequency in SARS-CoV-2 infection-related genes utilizing lung cancer genomic database Yuji Shibata, Shingo Matsumoto, Kiyotaka Yoh, Koichi Goto
72 [GO] 2020―Dec―16 Cancer treatment in the coronavirus disease pandemic Jia-Tao Zhang, Wen-Zhao Zhong, Yi-Long Wu
73 [GO] 2020―Jun―17 Checkpoint inhibitor pneumonitis mimicking COVID-19 infection during the COVID-19 pandemic Hsu-Liang Chang, Po-Ju Wei, Kuan-Li Wu, Hung-Ling Huang, Chih-Jen Yang
74 [GO] 2020―Jun―12 The treatment and outcome of a pulmonary sarcomatoid carcinoma patient infected with SARS-CoV-2 Kai Wang, Yang Liu, Tian Hu, Yumei Liu, Chao Liu
75 [GO] 2020―May―30 Covid-19 and lung cancer: A greater fatality rate? Jacobo Rogado, Cristina Pangua, Gloria Serrano-Montero, Berta Obispo, Almudena Martín Marino, Mar Pérez-Pérez, Ana López-Alfonso, Pedro Gullón, Miguel Ángel Lara
76 [GO] 2020―May―26 Optimizing lung cancer radiation treatment worldwide in COVID-19 outbreak Zhongxing Liao, Eleonor Rivin del Campo, Ahmed Salem, Qingsong Pang, Hui Liu, Jose Luis Lopez Guerra
77 [GO] 2020―May―11 Immune checkpoint inhibitors in SARS-COV-2 infected cancer patients: the spark that ignites the fire? Vincenzo Di Noia, Alessandro D’Aveni, Michela Squadroni, Giordano Berett, Giovanni Luca Ceresoli
78 [GO] 2020―May―06 Metronomic oral vinorelbine and lung cancer therapy during the COVID 19 pandemic: A single-center experience David Rossi
79 [GO] 2020―May―04 A favorable outcome of pneumonia COVID 19 in an advanced lung cancer patient with severe neutropenia: Is immunosuppression a risk factor for SARS-COV2 infection? María Sereno, Gerardo Gutiérrez-Gutiérrez, Carmen Sandoval, Sandra Falagan, Ana María Jimenez-Gordo, María Merino, Ramiro López-Menchaca, Patricia Martínez-Martin, Silvia Roa, Enrique Casado
 [1] 

79 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec